Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Evaluation of the Effect of Using Ultrasound Robots for Breast Cancer Screening: A Multicenter, Parallel-group, Cluster Randomized Controlled Trial [NA]
A multicenter, parallel-group, cluster randomized trial is evaluating the effectiveness of using ultrasound robots for breast cancer screeni…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients at High Risk for Breast Cancer
A prospective study to develop and clinically validate a blood-based in vitro diagnostic device that classifies individuals as high risk for…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: MRI-Guided Neoadjuvant Treatment De-Escalation in Stage II-III TNBC [Phase 2]
This clinical trial update notes a Phase 2 study evaluating MRI-guided neoadjuvant treatment de-escalation in stage II-III triple-negative b…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Self-management Interventions to Reduce Cardiovascular Risks in Breast Cancer Survivors [NA]
A University of Southern Queensland study aims to reduce cardiovascular risk in breast cancer survivors through self-management intervention…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer [Phase 1]
A Phase 1 clinical trial evaluating the MV-s-NAP vaccine for invasive, metastatic breast cancer is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: QL1706 for the Neoadjuvant Treatment of HR+/HER2- Breast Cancer [Phase 2]
This document reports that the Phase 2 trial of QL1706 for neoadjuvant treatment of HR+/HER2- breast cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Integrated Molecular Profiling in Advanced Cancers Trial
An ongoing trial, Integrated Molecular Profiling in Advanced Cancers, sponsored by University Health Network in Toronto, investigates using …
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Circulating Tumor DNA and Immunophenotyping as Potential Biomarkers With Regional Nodal Irradiation for Breast Cancer
A Mayo Clinic-led clinical trial update examining circulating tumor DNA and immunophenotyping as potential biomarkers in breast cancer patie…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: NEPA in Patients With HER2-positive or HER2-low Advanced Breast Cancer Treated With T-DXd
Clinical trial update indicates NEPA is being studied for patients with HER2-positive or HER2-low advanced breast cancer who are treated wit…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Breast cancEr, FITness and ExeRcise for Heart Health: The BE-FITTER Study [NA]
A BE-FITTER clinical trial from the University of Alberta is evaluating whether fitness and exercise can improve heart health in individuals…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery [NA]
A clinical trial comparing axillary radiotherapy versus axillary lymph node dissection in clinically node-positive breast cancer patients un…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast Cancer [Phase 3]
Phase 3 trial evaluating the efficacy and safety of TQB3616 in combination with Fulvestrant versus placebo in combination with Fulvestrant f…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: MIRAI-MRI: Comparing Screening MRI for Patients at High Risk for Breast Cancer Identified by Mirai and Tyrer-Cuzick [NA]
A recruiting clinical trial at the University of Massachusetts Worcester is evaluating MRI screening for breast cancer risk using MIRAI and …
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Hypofractionated vs. Conventional Regional Nodal Radiation Therapy for Patients With Invasive Breast Cancer [Phase 2]
Phase 2 trial comparing hypofractionated and conventional regional nodal radiation therapy for invasive breast cancer; currently listed as a…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC [Phase 1, Phase 2]
A Phase Ib/II clinical trial is evaluating multiple combination therapies with FWD1802 in ER+/HER2- breast cancer and related stages, and is…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Evaluation of Wellbeing and Patient Reported Outcomes After Open vs Robotic Mastectomy With DIEP Reconstruction [NA]
This clinical trial update outlines a study comparing wellbeing and patient-reported outcomes after open versus robotic mastectomy with DIEP…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer [Phase 2]
This document provides an update on the Phase 2 SMMART-ACT precision medicine trial. It targets patients with advanced breast, ovarian, panc…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating neoadjuvant endocrine therapy for ER-positive, HER2-negative early-stage breast cancer; the study is cur…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors [Phase 1]
A Phase 1 trial evaluating in situ immunomodulation using CDX-301, CDX-1140, and Poly-ICLC with radiation therapy in patients with unresecta…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Neoadjuvant Chemotherapy With Pyrotinib, Epirubicin and Cyclophosphamide Followed by Taxanes and Trastuzumab for HER-2+ Breast Cancer [Phase 2, Phase 3]
Clinical trial update on a neoadjuvant regimen combining pyrotinib with epirubicin and cyclophosphamide followed by taxanes and trastuzumab …
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing [NA]
A clinical trial update noting ongoing recruitment for monitoring patients with HR-positive, HER2-negative metastatic breast cancer treated …
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Physical Rehabilitation Evaluation and Optimal Physical Therapy (PRE-OPT) [NA]
PRE-OPT is a clinical trial evaluating physical rehabilitation and optimal physical therapy for breast cancer patients. The study status is …
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer [Phase 2]
Phase II single-arm trial evaluating low-dose capecitabine in patients with metastatic breast cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: WATD and Cancer-Related Fatigue: A Study For Patients Undergoing Anti-Cancer Treatment
This clinical trial update notes that the study examining WATD and cancer-related fatigue in patients undergoing anti-cancer treatment is cu…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
The document describes an ongoing clinical trial that collects peripheral blood or saliva samples for genetic epidemiology studies of famili…